GLP-1 SM 20mg Peptides
Precision begins with a clean, consistent standard you can trust in every experiment.
The Primavora GLP-1 SM lyophilized peptide vial is a laboratory-grade preparation designed for researchers who require exacting quality and dependable performance. This unflavored, single-use vial contains a total of 20mg of active peptide, carefully handled and packaged to support reliable method development and repeatable results.
- 20mg Glucagon-Like Peptide-1 (SM) – Provided as a lyophilized solid for controlled handling, enabling consistent reconstitution for assay development, receptor binding work, and analytical calibration where a well-defined peptide reference is required.
Engineered for laboratory workflows, the lyophilized format supports accurate aliquoting and convenient storage prior to reconstitution. Researchers can expect a uniform matrix that dissolves predictably in appropriate research solvents, helping minimize variability introduced by sample preparation. Each vial is sealed to protect integrity through transport and routine handling.
Every lot reflects Primavora’s standards-first approach. Identity and purity are verified using established analytical techniques, with comprehensive lot traceability maintained from sourcing through final packaging. Consistency, clarity of documentation, and careful control of handling conditions are central to ensuring that each vial performs to specification in the lab.
Suggested laboratory use: Suitable for research applications that require a defined GLP-1 SM peptide. The format is optimized for controlled reconstitution and precise measurement during in vitro work and analytical method building. This product is not intended for taste, sensory, or consumer use.
Quality and trust: Primavora is a USA-based research supplier focused on purity, consistency, and transparency. Batches are analytically tested to verify identity and composition, and documentation is maintained to support rigorous lab requirements. Each vial is packaged with care to help preserve stability until use.
For laboratory research only. Not for human or veterinary use. Not a drug, food, or cosmetic. Handle using standard laboratory safety practices.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
